Table Of Contents:

1 Introduction    9
1.1 Industry Definition and Research Scope    9
1.1.1 Industry Definition    9
1.1.2 Research Scope    10
1.2 Research Methodology    13
1.2.1 Overview of Market Research Methodology    13
1.2.2 Market Assumption    14
1.2.3 Secondary Data    14
1.2.4 Primary Data    14
1.2.5 Data Filtration and Model Design    16
1.2.6 Market Size/Share Estimation    17
1.2.7 Research Limitations    18
1.3 Executive Summary    19
2 Market Overview and Dynamics    22
2.1 Market Size and Forecast    22
2.1.1 Impact of COVID-19 on World Economy    23
2.1.2 Impact of COVID-19 on the Market    26
2.2 Major Growth Drivers    28
2.3 Market Restraints and Challenges    33
2.4 Emerging Opportunities and Market Trends    36
2.5 Porter’s Fiver Forces Analysis    40
3 Segmentation of Global Market by Product    45
3.1 Market Overview by Product    45
3.2 Kits & Assays    47
3.3 Analyzers & Instruments    48
3.4 Software & Services    49
4 Segmentation of Global Market by Technology    50
4.1 Market Overview by Technology    50
4.2 Polymerase Chain Reaction (PCR)    52
4.2.1 Real-Time PCR (rt-PCR)    53
4.2.2 Digital PCR (d-PCR)    54
4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)    55
4.4 Genetic Sequencing-based Technology    56
4.5 Microarray-based Technology    57
4.6 Other Technologies    58
5 Segmentation of Global Market by Application    59
5.1 Market Overview by Application    59
5.2 Infectious Disease    61
5.2.1 Respiratory Infections    63
5.2.2 Hospital Acquired Infections    64
5.2.3 Sexually Transmitted Infections    65
5.3 Gastrointestinal Infections    66
5.4 Oncology    67
5.5 Hepatitis    68
5.6 Prenatal/Neonatal Testing    69
5.7 Other Applications    70
6 Segmentation of Global Market by End User    71
6.1 Market Overview by End User    71
6.2 Hospitals    73
6.3 Clinics & Diagnostic Centers    74
6.4 Research and Academic Institutes    75
6.5 Other End Users    76
7 Segmentation of Global Market by Region    78
7.1 Geographic Market Overview 2019-2030    78
7.2 North America Market 2019-2030 by Country    84
7.2.1 Overview of North America Market    84
7.2.2 U.S.    88
7.2.3 Canada    92
7.2.4 Mexico    94
7.3 European Market 2019-2030 by Country    96
7.3.1 Overview of European Market    96
7.3.2 Germany    100
7.3.3 UK    102
7.3.4 France    104
7.3.5 Spain    106
7.3.6 Italy    108
7.3.7 Russia    110
7.3.8 Rest of European Market    112
7.4 Asia-Pacific Market 2019-2030 by Country    114
7.4.1 Overview of Asia-Pacific Market    114
7.4.2 Japan    118
7.4.3 China    121
7.4.4 Australia    124
7.4.5 India    126
7.4.6 South Korea    128
7.4.7 Rest of APAC Region    130
7.5 South America Market 2019-2030 by Country    132
7.5.1 Argentina    135
7.5.2 Brazil    137
7.5.3 Chile    139
7.5.4 Rest of South America Market    141
7.6 MEA Market 2019-2030 by Country    142
7.6.1 UAE    145
7.6.2 Saudi Arabia    147
7.6.3 South Africa    149
7.6.4 Other National Markets    151
8 Competitive Landscape    152
8.1 Overview of Key Vendors    152
8.2 New Product Launch, Partnership, Investment, and M&A    156
8.3 Company Profiles    157
Abacus Diagnostica Oy    157
Abbott Laboratories    159
Alere Inc.    160
Biocartis Group NV    161
Biomerieux SA    162
Bio-Rad Laboratories Inc    163
Danaher Corporation    164
DiaSorin S.p.A    165
DxNA LLC.    166
F. Hoffmann-La Roche Ltd.    167
Hologic, Inc.    168
Luminex Corporation    169
Meridian Bioscience Inc.    170
Mesa Biotech Inc.    171
QIAGEN N.V.    172
QuantuMDx Group Ltd.    173
Quidel Corporation    174
Spartan Biosciences Inc.    175
Thermo Fisher Scientific    176
9 Investing in Global Market: Risk Assessment and Management    177
9.1 Risk Evaluation of Global Market    177
9.2 Critical Success Factors (CSFs)    180
Related Reports and Products    183

List Of Tables:

Table 1. Snapshot of Global Point of Care (PoC) Molecular Diagnostics Market, 2019-2030    20
Table 2. Growth Rate of World Real GDP, 2017-2021    24
Table 3. Main Product Trends and Market Opportunities in Global Point of Care (PoC) Molecular Diagnostics Market    36
Table 4. Global Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    45
Table 5. Global Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    50
Table 6. Global Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn    52
Table 7. Global Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    59
Table 8. Global Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn    62
Table 9. Global Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn    71
Table 10. Global Point of Care (PoC) Molecular Diagnostics Market by Region, 2019-2030, $ mn    79
Table 11. Total Health Expenditure per capita in PPP International U.S. Dollars by Country    81
Table 12. Leading National Point of Care (PoC) Molecular Diagnostics Market, 2019 and 2030, $ mn    83
Table 13. North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn    86
Table 14. U.S. Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    90
Table 15. U.S. Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    90
Table 16. U.S. Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    90
Table 17. Canada Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    93
Table 18. Canada Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    93
Table 19. Canada Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    93
Table 20. Mexico Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    95
Table 21. Mexico Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    95
Table 22. Mexico Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    95
Table 23. Europe Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn    99
Table 24. Germany Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    101
Table 25. Germany Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    101
Table 26. Germany Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    101
Table 27. UK Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    103
Table 28. UK Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    103
Table 29. UK Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    103
Table 30. France Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    105
Table 31. France Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    105
Table 32. France Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    105
Table 33. Spain Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    107
Table 34. Spain Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    107
Table 35. Spain Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    107
Table 36. Italy Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    109
Table 37. Italy Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    109
Table 38. Italy Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    109
Table 39. Russia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    111
Table 40. Russia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    111
Table 41. Russia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    111
Table 42. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe by Country, 2019-2030, $ mn    113
Table 43. APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn    116
Table 44. Japan Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    120
Table 45. Japan Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    120
Table 46. Japan Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    120
Table 47. China Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    123
Table 48. China Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    123
Table 49. China Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    123
Table 50. Australia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    125
Table 51. Australia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    125
Table 52. Australia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    125
Table 53. India Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    127
Table 54. India Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    127
Table 55. India Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    127
Table 56. South Korea Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    129
Table 57. South Korea Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    129
Table 58. South Korea Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    129
Table 59. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC by Country, 2019-2030, $ mn    131
Table 60. South America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn    134
Table 61. Argentina Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    136
Table 62. Argentina Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    136
Table 63. Argentina Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    136
Table 64. Brazil Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    138
Table 65. Brazil Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    138
Table 66. Brazil Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    138
Table 67. Chile Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    140
Table 68. Chile Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    140
Table 69. Chile Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    140
Table 70. MEA Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn    144
Table 71. UAE Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    146
Table 72. UAE Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    146
Table 73. UAE Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    146
Table 74. Saudi Arabia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    148
Table 75. Saudi Arabia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    148
Table 76. Saudi Arabia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    148
Table 77. South Africa Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn    150
Table 78. South Africa Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn    150
Table 79. South Africa Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn    150
Table 80. Breakdown of Global Market by Key Vendor, 2019, 4
Table 81. Abacus Diagnostica Oy: Company Snapshot    157
Table 82. Abacus Diagnostica Oy: Business Segmentation    157
Table 83. Abacus Diagnostica Oy: Product Portfolio    158
Table 84. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn    158
Table 85. Abacus Diagnostica Oy: Recent Developments    158
Table 86. Risk Evaluation for Investing in Global Market, 2019-2030    178
Table 87. Critical Success Factors and Key Takeaways    181

List Of Figures:

Figure 1. Research Method Flow Chart    13
Figure 2. Breakdown of Primary Research    15
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation    17
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030    19
Figure 5. Global Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn    22
Figure 6. Impact of COVID-19 on Business    26
Figure 7. Primary Drivers and Impact Factors of Global Point of Care (PoC) Molecular Diagnostics Market    28
Figure 8. World Number of Deaths by Cause in 2017    31
Figure 9. World Number of Deaths from Cancers in 2017    32
Figure 10. Primary Restraints and Impact Factors of Global Point of Care (PoC) Molecular Diagnostics Market    33
Figure 11. Investment Opportunity Analysis    37
Figure 12. Porter’s Fiver Forces Analysis of Global Point of Care (PoC) Molecular Diagnostics Market    40
Figure 13. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue    45
Figure 14. Global Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)    46
Figure 15. Global Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn    47
Figure 16. Global Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn    48
Figure 17. Global Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn    49
Figure 18. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue    50
Figure 19. Global Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%)    51
Figure 20. Global Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn    52
Figure 21. Global Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn    53
Figure 22. Global Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn    54
Figure 23. Global Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn    55
Figure 24. Global Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn    56
Figure 25. Global Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn    57
Figure 26. Global Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn    58
Figure 27. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue    59
Figure 28. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)    60
Figure 29. Global Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn    61
Figure 30. Global Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn    63
Figure 31. Global Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn    64
Figure 32. Global Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn    65
Figure 33. Global Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn    66
Figure 34. Global Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn    67
Figure 35. Global Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn    68
Figure 36. Global Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn    69
Figure 37. Global Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn    70
Figure 38. Breakdown of Global Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue    71
Figure 39. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)    72
Figure 40. Global Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn    73
Figure 41. Global Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn    74
Figure 42. Global Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn    75
Figure 43. Global Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn    76
Figure 44. Global Market Snapshot by Region    78
Figure 45. Geographic Spread of Worldwide Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, % of Sales Revenue    79
Figure 46. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%)    80
Figure 47. Health Spending as a Share of GDP by Country, 2015 and 2030    82
Figure 48.  North American Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn    85
Figure 49. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue    86
Figure 50. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)    87
Figure 51. U.S. Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn    89
Figure 52. Canada Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn    92
Figure 53. Point of Care (PoC) Molecular Diagnostics Market in Mexico, 2015-2030, $ mn    94
Figure 54. European Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn    97
Figure 55. Breakdown of European Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue    98
Figure 56. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)    99
Figure 57. Point of Care (PoC) Molecular Diagnostics Market in Germany, 2019-2030, $ mn    100
Figure 58. Point of Care (PoC) Molecular Diagnostics Market in UK, 2019-2030, $ mn    102
Figure 59. Point of Care (PoC) Molecular Diagnostics Market in France, 2019-2030, $ mn    104
Figure 60. Point of Care (PoC) Molecular Diagnostics Market in Spain, 2019-2030, $ mn    106
Figure 61. Point of Care (PoC) Molecular Diagnostics Market in Italy, 2019-2030, $ mn    108
Figure 62. Point of Care (PoC) Molecular Diagnostics Market in Russia, 2019-2030, $ mn    110
Figure 63. Point of Care (PoC) Molecular Diagnostics Market in Rest of Europe, 2019-2030, $ mn    112
Figure 64. Asia-Pacific Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn    115
Figure 65. Breakdown of APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue    115
Figure 66. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)    117
Figure 67. Point of Care (PoC) Molecular Diagnostics Market in Japan, 2019-2030, $ mn    119
Figure 68. Point of Care (PoC) Molecular Diagnostics Market in China, 2019-2030, $ mn    122
Figure 69. Point of Care (PoC) Molecular Diagnostics Market in Australia, 2019-2030, $ mn    124
Figure 70. Point of Care (PoC) Molecular Diagnostics Market in India, 2019-2030, $ mn    126
Figure 71. Point of Care (PoC) Molecular Diagnostics Market in South Korea, 2019-2030, $ mn    128
Figure 72. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC, 2019-2030, $ mn    130
Figure 73. South America Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn    133
Figure 74. Breakdown of South America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue    133
Figure 75. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)    134
Figure 76. Point of Care (PoC) Molecular Diagnostics Market in Argentina, 2019-2030, $ mn    135
Figure 77. Point of Care (PoC) Molecular Diagnostics Market in Brazil, 2019-2030, $ mn    137
Figure 78. Point of Care (PoC) Molecular Diagnostics Market in Chile, 2019-2030, $ mn    139
Figure 79. Point of Care (PoC) Molecular Diagnostics Market in Rest of South America, 2019-2030, $ mn    141
Figure 80. Point of Care (PoC) Molecular Diagnostics Market in Middle East and Africa (MEA), 2019-2030, $ mn    143
Figure 81. Breakdown of MEA Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue    143
Figure 82. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)    144
Figure 83. Point of Care (PoC) Molecular Diagnostics Market in UAE, 2019-2030, $ mn    145
Figure 84. Point of Care (PoC) Molecular Diagnostics Market in Saudi Arabia, 2019-2030, $ mn    147
Figure 85. Point of Care (PoC) Molecular Diagnostics Market in South Africa, 2019-2030, $ mn    149
Figure 86. Growth Stage of Global Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period    152

Key Players: (this may not be a complete list and extra companies can be added upon request)

Abacus Diagnostica Oy 
Abbott Laboratories 
Alere Inc. 
Biocartis Group NV 
Biomerieux SA 
Bio-Rad Laboratories Inc 
Danaher Corporation 
DiaSorin S.p.A 
DxNA LLC. 
F. Hoffmann-La Roche Ltd. 
Hologic, Inc. 
Luminex Corporation 
Meridian Bioscience Inc. 
Mesa Biotech Inc. 
QIAGEN N.V. 
QuantuMDx Group Ltd. 
Quidel Corporation 
Spartan Biosciences Inc. 
Thermo Fisher Scientific